{
  "id": 5071885,
  "title": "WHO restricts Ervebo use in Bundibugyo outbreak",
  "url": "https://urgent.news/2026/09/02/who-restricts-ervebo-use-in-bundibugyo-outbreak",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T10:45:54.000Z",
  "source": {
    "name": "Premium Times",
    "slug": "premium-times",
    "url": "https://www.premiumtimesng.com/health/health-news/906969-who-restricts-ervebo-use-in-bundibugyo-outbreak.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "WHO said Ervebo should currently be used against Bundibugyo virus only within a research protocol to generate evidence on its effectiveness, rather than through broader routine outbreak vaccination. The post WHO restricts Ervebo use in Bundibugyo outbreak appeared first on Premium Times Nigeria .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nairametrics",
        "title": "WHO rejects wide rollout of Ervebo Vaccine in deadly DR Congo Ebola outbreak",
        "url": "https://urgent.news/2026/09/02/who-rejects-wide-rollout-of-ervebo-vaccine-in-deadly-dr-congo-ebola",
        "published": "2026-09-02T09:10:24.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}